1161 21st Ave S, MCN B-3215
615-875-0014
Education:
- College: The University of Texas at Austin (Austin, TX), B.S., May 2004 (Biochemistry)
- Professional or graduate: Stanford University (Stanford, CA), Ph.D., September 2009 (Cancer Biology Program)
- Safety and Utility of Phage Integrases for Gene Therapy
- Postgraduate Training: Postdoctoral Fellowship, Nephrology T32 and Hematology T32
- Baylor College of Medicine, Matthew H. Wilson, September 2009-September 2013
Academic Appointments:
- Summer Undergraduate Research Program. Mark Bedford, Ph.D., The University of Texas M.D. Anderson - Science Park, Department of Carcinogenesis, 2002.
- Honors thesis. Karen Browning, Ph.D., The University of Texas at Austin, Department of Chemistry and Biochemistry, 2000-2004.
- Doctoral thesis. Michele Calos, Ph.D., Stanford University School of Medicine, Department of Genetics, 2004-2009.
- Postdoctoral Fellowship. Matthew Wilson, M.D., Ph.D., Baylor College of Medicine, Department of Medicine, Division of Nephrology, 2009-2013.
- Research Instructor. Matthew Wilson, M.D., Ph.D., Vanderbilt University Medical Center, Department of Medicine, Division of Nephrology and Hypertension, 2013-2018.
- Assistant Professor. Vanderbilt University Medical Center, Department of Medicine, Division of Nephrology and Hypertension, 2018-present.
- Research Scientist. Department of Veterans Affairs, Research and Development Service, 2015-present.
Professional Organizations:
- American Society of Gene (and Cell) Therapy, 2005-present
- Physical Delivery, Therapeutics & Vector Development Committee, 2018-2021
- American Society of Nephrology, 2014-present